Atherosclerosis Wire
Comprehensive News Feed for Atherosclerosis.
Results 1 - 20 of 80 in Atherosclerosis
-
NicOx SA Announces NCX 6560 Meets Primary and Secondary Objectives in First-in- Man Study
... in the key processes underlying the most common cardiovascular disorders, such as endothelium dysfunction, atherosclerosis and thrombosis. NCX 6560 is a New Chemical Entity (NCE) that is an NO- donating atorvastatin, which is designed to provide ... Comment?
-
NicOx announces NCX 6560 meets primary and secondary objectives in first-in- man study
... in the key processes underlying the most common cardiovascular disorders, such as endothelium dysfunction, atherosclerosis and thrombosis. NCX 6560 is a New Chemical Entity (NCE) that is an NO- donating atorvastatin, which is designed to provide ... Comment?
-
Lipitor and Zocor: Are they equally effective?
... His research interests are the application of imaging technology to early recognition and treatment of atherosclerosis. He is passionate about patients' involvement in their health issues. "The Internet and patient education present ideal synergies ... Comment?
-
Scientists Reveal A New Mechanism That Increases Atherosclerosis In Mice
w/Photo
New research from Rockefeller University now shows that when chronically activated, the protein rejiggers how cholesterol is broken down in and cleared from the liver, a disturbance that can lead to high levels of the waxy substance or worse, full-blown atherosclerosis. Comment?
-
Statins May Worsen Fatigue in Heart Failure Patients
... statins may help prevent blood clots in people with cardiovascular disease. Previous research has linked atherosclerosis, a condition in which fatty material builds up along artery walls, and venous thrombosis (VTE). Researchers from Albert Einstein ... Comment?
-
Statins may worsen fatigue in heart failure patients
... statins may help prevent blood clots in people with cardiovascular disease. Previous research has linked atherosclerosis, a condition in which fatty material builds up along artery walls, and venous thrombosis (VTE). Researchers from Albert Einstein ... Comment?
-
... the stent. Over time, the lining of the artery grows over the stent. Angioplasty is performed to treat atherosclerosis, a condition that occurs when a material called plaque builds up in the inner walls of the arteries. When plaque builds up in the ... Comment?
-
Updates to Canadian Recommendations for Lipid Management Reinforce...
... target lipid levels are provided. The 2009 lipid guidelines recommend that all patients with evidence of atherosclerosis, regardless of age, should be treated as being a high-risk patient. Similarly, all adults with diabetes should have a complete ... Comment?
-
Study Demonstrates Livalo Is an Efficacious Treatment for Achieving Lipid Goals
... Education Program (NCEP) Adult Treatment Panel (ATP) III guidelines, but was superior based on European Atherosclerosis Society (EAS) guidelines. Although statins are proven to reduce LDL-C levels, many patients treated with statins fail to reach or ... Comment?
-
Study Demonstrates LIVALO(R) Is An Efficacious Treatment For Achieving Lipid Goals
... Education Program (NCEP) Adult Treatment Panel (ATP) III guidelines, but was superior based on European Atherosclerosis Society (EAS) guidelines. Although statins are proven to reduce LDL-C levels, many patients treated with statins fail to reach or ... Comment?
-
LIVALO statin effective than simvastatin in reducing lipid levels
... Education Program (NCEP) Adult Treatment Panel (ATP) III guidelines, but was superior based on European Atherosclerosis Society (EAS) guidelines. Although statins are proven to reduce LDL-C levels, many patients treated with statins fail to reach or ... Comment?
-
Treatments for Atherosclerosis
Treatments for atherosclerosis range from changing your lifestyle, to medications and then to more aggressive treatments such as angioplasty. Comment?
-
Reportlinker Adds Statins: the World Market, 2009-2024 Report
... Cholesterol and Triglycerides 2.2 Lipoproteins Transport Cholesterol and Triglycerides 2.3 Dyslipidaemia and Atherosclerosis 2.4 Cholesterol Risk Levels 2.5 The Fredrickson/World Health Organization (WHO) Classification of Dyslipidaemia 2.6 ... Comment?
-
Merck Expands Alliance with Belgium's Galapagos
... said it has expanded its drug alliance with Merck & Co. Inc. (MRK) to include drugs that could treat atherosclerosis, the hardened arteries that cause heart attacks and strokes. MAIN FACTS: -Galapagos' alliance milestones will more than double to ... Comment?
-
Resverlogix Appoints A. Brad Cann as Chief Financial Officer
... with significant unmet medical needs. The Company is developing an oral small molecule therapeutic to treat atherosclerosis and cardiovascular disease. "We are very pleased to add Brad to our team of professionals. He has a number of areas of ... Comment?
-
Dr. Dustin Ballard: When smelling like a fish is worth it
... College of Cardiology seems to suggest otherwise. It found significantly less hardening of the arteries (atherosclerosis) in middle-aged Japanese men compared with middle-aged American men - but only in Japanese men living in Japan. In other words, ... 7 comments
-
FDA approves Daiichi Sankyo's sNDA for Welchol
... puts them at increased risk for cardiovascular disease, said Evan A. Stein, MD, PhD, Director, Metabolic & Atherosclerosis Research Center, Cincinnati, OH. "The pivotal trial of Welchol in this pediatric patient population demonstrated that Welchol, ... Comment?
-
Welchol Receives FDA Approval to Lower LDL Cholesterol in Pediatric Patients
... them at increased risk for cardiovascular diseasea ," said Evan A. Stein, MD, PhD, Director, Metabolic & Atherosclerosis Research Center, Cincinnati, OH. "The pivotal trial of Welchol in this pediatric patient population demonstrated that Welchol, ... Comment?
-
... the stent. Over time, the lining of the artery grows over the stent. Angioplasty is performed to treat atherosclerosis, a condition that occurs when a material called plaque builds up in the inner walls of the arteries. When plaque builds up in the ... Comment?
-
Resverlogix RVX-208 Second Clinical Trial Demonstrates Success On ...
... often referred to as "good" cholesterol . ApoA-I is generally endorsed as a key protective factor against atherosclerosis and cardiovascular disease with 40% of all first heart attack patients having low ApoA-I. Resverlogix's Phase 1b/2a study ... Comment?
Atherosclerosis Forum
Most Popular
- Arkansas 10-Year-Old Won't Pledge Allegiance Until Gays Gain Equality. - 627 comments
- 5 types of men women hate - 132 comments
- Obama's Muslim Problem - Has he been too conciliatory? - 169 comments
- Napolitano pronounces US border more secure now - 108 comments
- Sarah Palin to Visit Fort Hood - 162 comments
- Catholic Church gives D.C. ultimatum on same-sex marriage issue - 324 comments
- Pat Robertson on Ft. Hood: Islam is 'not a religion' and... - 93 comments
- KSP arrests two Washington Co., KY deputies - 77 comments
- Churches targeted by 'gay' intimidation campaign - 119 comments
- Ex-congressman gets 13 years in freezer cash case - 80 comments
|
Reach local customers. Engage a specific demographic. Maximize business-to-business opportunities. Topix can deliver your message.
|
Copyright ©2009 Topix LLC
